specifically , we provide integrated national preferred provider organization , also known as ppo , network access , electronic claims repricing , and network and data management to healthcare payers , including self-insured employers , medical insurance carriers , ppos and third party administrators . we believe we are uniquely positioned in the marketplace to make a contribution that our competitors do not . the differentiators include our open electronic network for electronic transactions with no equity ownership in businesses engaged in the front-end ( i.e . , physician practice management software system vendors and other physician desk top vendors ) or in the back-end ( i.e . , payers , laboratories and pharmacies ) . with our neutral position , we believe that we can better attract both front-end and back-end partners who may be more comfortable doing business with a non-competitive partner . another competitive differentiator is our presence in the clinical market . with the nation 's largest clinical laboratories as long-time customers , we have worked in partnership with them to develop customized laboratory communication tools and services that are unparalleled in the industry . we also have the oldest and most established e-prescribing network in the nation , offering connectivity to over 30,000 pharmacies nationwide . our e-prescribing solutions improve efficiency by eliminating the need to process prescriptions and refill authorizations via paper . we offer both a front-end desktop solution , prescribe tm , and online refill authorization via www.medavanthealth.com . combined , we process more than 400,000 prescriptions or refills per month . acquisitions on december 31 , 2002 , we acquired all of the outstanding stock of medunite , inc. for $ 10 million in cash and the issuance of an aggregate of $ 13.4 million principal amount of 4 % convertible promissory notes . in addition , we paid approximately $ 6.7 million in transaction and exit related costs . interest on the convertible promissory notes is payable in cash on a quarterly basis . the convertible promissory notes ( now currently payable at a maturity value of $ 13.1 million after a claim setoff against the escrow in december 2003 ) are payable in full on december 31 , 2008 , and are convertible into an aggregate of 716,968 shares ( originally 731,322 shares before the claim setoff ) of our common stock if our revenues resulting from business with the former medunite owners exceed certain thresholds over a three and one-half year period from the date of acquisition . we do not anticipate that the former medunite owners will meet all of the thresholds defined in the promissory note . on march 2 , 2004 , we acquired planvista , a company that provides medical cost containment and business process outsourcing solutions for the medical insurance and managed care industries , as well as services for healthcare providers , including individual providers , preferred provider organizations and other provider groups for 3,600,000 shares of our common stock issued to planvista shareholders valued at $ 59.8 million ( based on the average closing price of our common stock for the day of and the two days before and after december 8 , 2003 , the date of the announcement of the definitive agreement ) . we also assumed debt and other liabilities of planvista , totaling $ 46.4 million and paid $ 1.3 million in acquisition-related costs . additionally , we raised $ 24.1 million in a private placement sale of 1,691,227 shares of our common stock to investment entities affiliated with general atlantic llc , commonwealth associates and other parties to partially fund repayment of certain of planvista 's debts and other obligations outstanding at the time of the acquisition . the acquisition has enabled us to become the only entity in healthcare that offers a nationwide clearinghouse and a nationwide ppo network , delivering end-to-end services to our customers . upon completion of the acquisition , each share of planvista 's outstanding common stock was cancelled and converted into 0.08271 shares of our common stock and each holder of planvista series c preferred stock received 51.5292 shares of our common stock in exchange for each share of planvista series c preferred stock , 24 representing approximately 23 % of our common stock on a fully converted basis , and the holders of our outstanding stock , options and warrants retained approximately 77 % of the company following the transaction . planvista 's operations are included in our transaction services segment commencing march 2004. on february 14 , 2006 , we acquired substantially all the assets and operations of zeneks , inc. , a privately held bill negotiation services company based in tampa , florida , for $ 225,000 plus assumed liabilities . zeneks was incorporated in 1998 and was established as a medical cost containment company . they have relationships with numerous providers throughout the country . we expect to integrate the zeneks operations into our current bill negotiation system by the end of the first quarter of fiscal 2006. sale of assets on june 30 , 2004 , we sold certain assets and liabilities of our laboratory communication solutions segment that were used in our non-core contract manufacturing business to a new entity owned by a former executive of the company for $ 4.5 million in cash . under terms of the sale agreement , we received $ 3.5 million in cash at closing and received the balance of $ 1.0 million in cash in july and august 2004 following the presentation of the final accounting . as part of the disposition , we agreed to purchase certain component parts from the new entity for use in our laboratory communication solutions business on a non-exclusive basis at a fixed price deemed to be at fair market value by management . story_separator_special_tag consolidated sg & a increased for 2004 by $ 12.2 million , or 34 % , to $ 48.0 million from consolidated sg & a of $ 35.8 million for 2003. consolidated sg & a expenses as a percentage of consolidated revenues increased to 53 % in 2004 from 50 % in 2003. sg & a expenses classified by our reportable segments are as follows : replace_table_token_13_th transaction services segment sg & a expenses for the year ended december 31 , 2004 increased by $ 13.3 million , or 44 % over 2003. the primary cause of the increase was the addition of sg & a expenses from planvista for ten months in the 2004 period ( increase of $ 10.5 million ) . additionally , while we achieved significant reductions in expenses from our medunite acquisition over the course of 2003 , these savings have been offset by increased expenditures related to our ongoing efforts to comply with the sarbanes-oxley act of 2002 during 2004 ( increase of $ 1.7 million ) . laboratory communications solutions segment sg & a expenses for 2004 decreased by $ 1.1 million , or 20 % from 2003 and segment sg & a expenses as a percentage of segment net revenues increased to 23 % in 2004 from 22 % in 2003. the decreases in dollars are primarily due to a reduction in expenses related to the sale our contract manufacturing assets on june 30 , 2004. depreciation and amortization . consolidated depreciation and amortization increased by $ 3.4 million to $ 9.8 million for 2004 from $ 6.3 million for 2003. this increase was primarily due to approximately $ 3.5 million for the amortization of intangible assets acquired in the planvista acquisition in the transaction services segment ; offset by a decrease in depreciation expense in the laboratory communication solutions segment due to the sale of our manufacturing assets . depreciation and amortization classified by our reportable segments is as follows : replace_table_token_14_th loss on disposal of assets . in 2004 , we recorded a consolidated loss of disposal asset $ 47,000. this loss is related to the disposition of contract manufacturing assets in our laboratory communication solutions segment that were sold to a new entity formed by a former executive on june 30 , 2004 of $ 68,000 ; and $ 5,000 of miscellaneous items offset by $ 26,000 in gains on vehicles and other equipment sold . as a result of the consolidation of the proxymed and medunite offices in atlanta in february 2003 , we recorded $ 0.1 million in losses during 2003 primarily related to the disposition of certain assets owned and leased that were acquired in the acquisition of mdp corporation in 2001. litigation settlement . in december 2004 , we settled an outstanding preacquisition contingency related to planvista for $ 0.2 million , net of insurance reimbursement and is recorded in our transaction services segment . 30 operating income ( loss ) . as a result of the foregoing , the consolidated operating loss for 2004 was $ 2.0 million compared to an operating loss of $ 3.6 million for 2003. operating loss classified by our reportable segments is as follows : replace_table_token_15_th other income ( expense ) , net . during 2004 , we settled a long-term liability assumed in the acquisition of medunite for $ 0.8 million . the liability was being carried at its present value of $ 0.9 million . the resulting gain of $ 0.1 million is reflected as other income . additionally , in conjunction with our distribution and marketing agreement with planvista for claims repricing services signed in june 2003 , we received a warrant to purchase up to 15 % of planvista common stock that expired in december 2003. the warrant was initially valued at $ 0.5 million and recorded as an asset . upon expiration of the warrant in december 2003 , we recorded an impairment loss in the amount of $ 0.5 million ( representing the original value of the warrant ) for the 2003 year . interest expense , net . consolidated net interest expense for the 2004 was $ 1.9 million compared to $ 0.9 million for the same period last year . this increase in expense is primarily due to the assumption of debt in conjunction with the planvista acquisition ( increase of $ 1.2 million ) . interest expense for the future is expected to be at levels above those in 2004 due to the senior debt assumed from planvista . net loss . as a result of the foregoing , consolidated net loss for 2004 was $ 3.8 million compared to consolidated net loss of $ 5.0 million for 2003. story_separator_special_tag million in a private placement sale of our common stock and drew down $ 4.4 million on our then asset-based line of credit . these funds , along with available cash resources , were used to satisfy $ 27.4 million of planvista 's debt and other obligations outstanding as of the effective time of the acquisition . at the time of its acquisition by the company , planvista was involved in various lawsuits and threatened litigation . to date , a significant number of these cases have been settled or dismissed and resulted in $ 0.7 million charged to goodwill and $ 0.2 million charged to expense in 2004 . 32 in 2003 , net cash provided by operating activities totaled $ 1.5 million . cash used for investing activities totaled $ 9.6 million and consisted primarily of payments of costs related to the acquisition of medunite , capital expenditures and capitalized software . cash used in financing activities totaled $ 3.0 million mainly due to repayments of notes payable , other long-term debt , and payments related to capital leases . in december 2003 , we closed on a $ 12.5 million asset-based line of credit with our commercial bank . borrowing under such facility was subject to eligible

liquidity and capital resources during the years ended december 31 , 2005 and 2004 , net cash provided by operating activities totaled $ 5.2 million and $ 1.8 million , respectively . the 2004 amounts included $ 4.0 million to pay certain acquisition-related expenses of planvista outstanding as of the effective date of the acquisition . cash ( used in ) provided by investing activities for the years ended december 31 , 2005 and 2004 totaled ( $ 2.8 ) million and $ 0.7 million , respectively . the 2005 amounts relate primarily to the funding of capital expenditures for our technical infrastructure , administrative systems and capitalization of internally developed systems , while the 2004 amounts consisted primarily of $ 0.8 million in net cash acquired from planvista and $ 4.5 million received from the sale of our contract manufacturing assets , offset by $ 0.9 million in costs related to the acquisitions of planvista and medunite and $ 4.3 million in capital expenditures and capitalized software . cash ( used in ) provided by financing activities for the years ended december 31 , 2005 and 2004 , totaled ( $ 9.2 ) million and $ 4.5 million , respectively . the 2005 amounts consist primarily of repayment of notes payable , other long term debt and capital leases , offset by proceeds from the sale of our common stock to our chief executive officer during the second quarter of 2005 and borrowings on our lines of credit and notes payable . the 2004 amounts consisted of a $ 24.1 million private placement of our common stock , and proceeds from the exercise of stock options and warrants for $ 8.8 million , offset by $ 28.3 million in repayments of notes payable , other long-term debt , and payments related to capital leases ( including $ 27.4 million for the retirement of debts and other obligations of planvista upon the consummation of the acquisition ) . on april 18 , 2005 , we closed a three year , $ 15.0 million senior asset based facility which was secured by all assets of the combined entities with wachovia bank , n.a .


 Write a concise suspicious activity report of the following text delimited by triple backquotes. Return your response as a formal report which covers the key points highlighting the location,dates,entity names and account holder information in chronological order of the text.
     ```liquidity and capital resources during the years ended december 31 , 2005 and 2004 , net cash provided by operating activities totaled $ 5.2 million and $ 1.8 million , respectively . the 2004 amounts included $ 4.0 million to pay certain acquisition-related expenses of planvista outstanding as of the effective date of the acquisition . cash ( used in ) provided by investing activities for the years ended december 31 , 2005 and 2004 totaled ( $ 2.8 ) million and $ 0.7 million , respectively . the 2005 amounts relate primarily to the funding of capital expenditures for our technical infrastructure , administrative systems and capitalization of internally developed systems , while the 2004 amounts consisted primarily of $ 0.8 million in net cash acquired from planvista and $ 4.5 million received from the sale of our contract manufacturing assets , offset by $ 0.9 million in costs related to the acquisitions of planvista and medunite and $ 4.3 million in capital expenditures and capitalized software . cash ( used in ) provided by financing activities for the years ended december 31 , 2005 and 2004 , totaled ( $ 9.2 ) million and $ 4.5 million , respectively . the 2005 amounts consist primarily of repayment of notes payable , other long term debt and capital leases , offset by proceeds from the sale of our common stock to our chief executive officer during the second quarter of 2005 and borrowings on our lines of credit and notes payable . the 2004 amounts consisted of a $ 24.1 million private placement of our common stock , and proceeds from the exercise of stock options and warrants for $ 8.8 million , offset by $ 28.3 million in repayments of notes payable , other long-term debt , and payments related to capital leases ( including $ 27.4 million for the retirement of debts and other obligations of planvista upon the consummation of the acquisition ) . on april 18 , 2005 , we closed a three year , $ 15.0 million senior asset based facility which was secured by all assets of the combined entities with wachovia bank , n.a .
```    
 Suspicious Activity Report : specifically , we provide integrated national preferred provider organization , also known as ppo , network access , electronic claims repricing , and network and data management to healthcare payers , including self-insured employers , medical insurance carriers , ppos and third party administrators . we believe we are uniquely positioned in the marketplace to make a contribution that our competitors do not . the differentiators include our open electronic network for electronic transactions with no equity ownership in businesses engaged in the front-end ( i.e . , physician practice management software system vendors and other physician desk top vendors ) or in the back-end ( i.e . , payers , laboratories and pharmacies ) . with our neutral position , we believe that we can better attract both front-end and back-end partners who may be more comfortable doing business with a non-competitive partner . another competitive differentiator is our presence in the clinical market . with the nation 's largest clinical laboratories as long-time customers , we have worked in partnership with them to develop customized laboratory communication tools and services that are unparalleled in the industry . we also have the oldest and most established e-prescribing network in the nation , offering connectivity to over 30,000 pharmacies nationwide . our e-prescribing solutions improve efficiency by eliminating the need to process prescriptions and refill authorizations via paper . we offer both a front-end desktop solution , prescribe tm , and online refill authorization via www.medavanthealth.com . combined , we process more than 400,000 prescriptions or refills per month . acquisitions on december 31 , 2002 , we acquired all of the outstanding stock of medunite , inc. for $ 10 million in cash and the issuance of an aggregate of $ 13.4 million principal amount of 4 % convertible promissory notes . in addition , we paid approximately $ 6.7 million in transaction and exit related costs . interest on the convertible promissory notes is payable in cash on a quarterly basis . the convertible promissory notes ( now currently payable at a maturity value of $ 13.1 million after a claim setoff against the escrow in december 2003 ) are payable in full on december 31 , 2008 , and are convertible into an aggregate of 716,968 shares ( originally 731,322 shares before the claim setoff ) of our common stock if our revenues resulting from business with the former medunite owners exceed certain thresholds over a three and one-half year period from the date of acquisition . we do not anticipate that the former medunite owners will meet all of the thresholds defined in the promissory note . on march 2 , 2004 , we acquired planvista , a company that provides medical cost containment and business process outsourcing solutions for the medical insurance and managed care industries , as well as services for healthcare providers , including individual providers , preferred provider organizations and other provider groups for 3,600,000 shares of our common stock issued to planvista shareholders valued at $ 59.8 million ( based on the average closing price of our common stock for the day of and the two days before and after december 8 , 2003 , the date of the announcement of the definitive agreement ) . we also assumed debt and other liabilities of planvista , totaling $ 46.4 million and paid $ 1.3 million in acquisition-related costs . additionally , we raised $ 24.1 million in a private placement sale of 1,691,227 shares of our common stock to investment entities affiliated with general atlantic llc , commonwealth associates and other parties to partially fund repayment of certain of planvista 's debts and other obligations outstanding at the time of the acquisition . the acquisition has enabled us to become the only entity in healthcare that offers a nationwide clearinghouse and a nationwide ppo network , delivering end-to-end services to our customers . upon completion of the acquisition , each share of planvista 's outstanding common stock was cancelled and converted into 0.08271 shares of our common stock and each holder of planvista series c preferred stock received 51.5292 shares of our common stock in exchange for each share of planvista series c preferred stock , 24 representing approximately 23 % of our common stock on a fully converted basis , and the holders of our outstanding stock , options and warrants retained approximately 77 % of the company following the transaction . planvista 's operations are included in our transaction services segment commencing march 2004. on february 14 , 2006 , we acquired substantially all the assets and operations of zeneks , inc. , a privately held bill negotiation services company based in tampa , florida , for $ 225,000 plus assumed liabilities . zeneks was incorporated in 1998 and was established as a medical cost containment company . they have relationships with numerous providers throughout the country . we expect to integrate the zeneks operations into our current bill negotiation system by the end of the first quarter of fiscal 2006. sale of assets on june 30 , 2004 , we sold certain assets and liabilities of our laboratory communication solutions segment that were used in our non-core contract manufacturing business to a new entity owned by a former executive of the company for $ 4.5 million in cash . under terms of the sale agreement , we received $ 3.5 million in cash at closing and received the balance of $ 1.0 million in cash in july and august 2004 following the presentation of the final accounting . as part of the disposition , we agreed to purchase certain component parts from the new entity for use in our laboratory communication solutions business on a non-exclusive basis at a fixed price deemed to be at fair market value by management . story_separator_special_tag consolidated sg & a increased for 2004 by $ 12.2 million , or 34 % , to $ 48.0 million from consolidated sg & a of $ 35.8 million for 2003. consolidated sg & a expenses as a percentage of consolidated revenues increased to 53 % in 2004 from 50 % in 2003. sg & a expenses classified by our reportable segments are as follows : replace_table_token_13_th transaction services segment sg & a expenses for the year ended december 31 , 2004 increased by $ 13.3 million , or 44 % over 2003. the primary cause of the increase was the addition of sg & a expenses from planvista for ten months in the 2004 period ( increase of $ 10.5 million ) . additionally , while we achieved significant reductions in expenses from our medunite acquisition over the course of 2003 , these savings have been offset by increased expenditures related to our ongoing efforts to comply with the sarbanes-oxley act of 2002 during 2004 ( increase of $ 1.7 million ) . laboratory communications solutions segment sg & a expenses for 2004 decreased by $ 1.1 million , or 20 % from 2003 and segment sg & a expenses as a percentage of segment net revenues increased to 23 % in 2004 from 22 % in 2003. the decreases in dollars are primarily due to a reduction in expenses related to the sale our contract manufacturing assets on june 30 , 2004. depreciation and amortization . consolidated depreciation and amortization increased by $ 3.4 million to $ 9.8 million for 2004 from $ 6.3 million for 2003. this increase was primarily due to approximately $ 3.5 million for the amortization of intangible assets acquired in the planvista acquisition in the transaction services segment ; offset by a decrease in depreciation expense in the laboratory communication solutions segment due to the sale of our manufacturing assets . depreciation and amortization classified by our reportable segments is as follows : replace_table_token_14_th loss on disposal of assets . in 2004 , we recorded a consolidated loss of disposal asset $ 47,000. this loss is related to the disposition of contract manufacturing assets in our laboratory communication solutions segment that were sold to a new entity formed by a former executive on june 30 , 2004 of $ 68,000 ; and $ 5,000 of miscellaneous items offset by $ 26,000 in gains on vehicles and other equipment sold . as a result of the consolidation of the proxymed and medunite offices in atlanta in february 2003 , we recorded $ 0.1 million in losses during 2003 primarily related to the disposition of certain assets owned and leased that were acquired in the acquisition of mdp corporation in 2001. litigation settlement . in december 2004 , we settled an outstanding preacquisition contingency related to planvista for $ 0.2 million , net of insurance reimbursement and is recorded in our transaction services segment . 30 operating income ( loss ) . as a result of the foregoing , the consolidated operating loss for 2004 was $ 2.0 million compared to an operating loss of $ 3.6 million for 2003. operating loss classified by our reportable segments is as follows : replace_table_token_15_th other income ( expense ) , net . during 2004 , we settled a long-term liability assumed in the acquisition of medunite for $ 0.8 million . the liability was being carried at its present value of $ 0.9 million . the resulting gain of $ 0.1 million is reflected as other income . additionally , in conjunction with our distribution and marketing agreement with planvista for claims repricing services signed in june 2003 , we received a warrant to purchase up to 15 % of planvista common stock that expired in december 2003. the warrant was initially valued at $ 0.5 million and recorded as an asset . upon expiration of the warrant in december 2003 , we recorded an impairment loss in the amount of $ 0.5 million ( representing the original value of the warrant ) for the 2003 year . interest expense , net . consolidated net interest expense for the 2004 was $ 1.9 million compared to $ 0.9 million for the same period last year . this increase in expense is primarily due to the assumption of debt in conjunction with the planvista acquisition ( increase of $ 1.2 million ) . interest expense for the future is expected to be at levels above those in 2004 due to the senior debt assumed from planvista . net loss . as a result of the foregoing , consolidated net loss for 2004 was $ 3.8 million compared to consolidated net loss of $ 5.0 million for 2003. story_separator_special_tag million in a private placement sale of our common stock and drew down $ 4.4 million on our then asset-based line of credit . these funds , along with available cash resources , were used to satisfy $ 27.4 million of planvista 's debt and other obligations outstanding as of the effective time of the acquisition . at the time of its acquisition by the company , planvista was involved in various lawsuits and threatened litigation . to date , a significant number of these cases have been settled or dismissed and resulted in $ 0.7 million charged to goodwill and $ 0.2 million charged to expense in 2004 . 32 in 2003 , net cash provided by operating activities totaled $ 1.5 million . cash used for investing activities totaled $ 9.6 million and consisted primarily of payments of costs related to the acquisition of medunite , capital expenditures and capitalized software . cash used in financing activities totaled $ 3.0 million mainly due to repayments of notes payable , other long-term debt , and payments related to capital leases . in december 2003 , we closed on a $ 12.5 million asset-based line of credit with our commercial bank . borrowing under such facility was subject to eligible

